Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in patients with recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC). Sun, L., Cohen, R. B., Colevas, A. LIPPINCOTT WILLIAMS & WILKINS. 2023

View details for Web of Science ID 001053772003160